GAMMA Investing LLC Raises Stock Position in Molina Healthcare, Inc (NYSE:MOH)

GAMMA Investing LLC raised its position in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 126.8% in the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,025 shares of the company's stock after purchasing an additional 1,132 shares during the quarter. GAMMA Investing LLC's holdings in Molina Healthcare were worth $667,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the company. Rothschild Investment LLC boosted its holdings in shares of Molina Healthcare by 126.3% in the first quarter. Rothschild Investment LLC now owns 86 shares of the company's stock worth $28,000 after buying an additional 48 shares during the last quarter. Colonial Trust Co SC raised its holdings in Molina Healthcare by 930.0% during the 4th quarter. Colonial Trust Co SC now owns 103 shares of the company's stock valued at $30,000 after buying an additional 93 shares during the period. Hurley Capital LLC bought a new position in shares of Molina Healthcare during the fourth quarter valued at approximately $55,000. EverSource Wealth Advisors LLC grew its holdings in shares of Molina Healthcare by 81.5% in the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after purchasing an additional 88 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. increased its holdings in Molina Healthcare by 337.0% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock worth $58,000 after purchasing an additional 155 shares during the period. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Molina Healthcare

In related news, Director Richard M. Schapiro sold 669 shares of the firm's stock in a transaction on Tuesday, April 29th. The shares were sold at an average price of $320.50, for a total transaction of $214,414.50. Following the sale, the director owned 11,244 shares in the company, valued at approximately $3,603,702. This trade represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Joseph M. Zubretsky sold 87,500 shares of the company's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $320.06, for a total transaction of $28,005,250.00. Following the completion of the transaction, the chief executive officer owned 257,715 shares of the company's stock, valued at approximately $82,484,262.90. This trade represents a 25.35% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.

Wall Street Analysts Forecast Growth

MOH has been the subject of a number of recent research reports. Sanford C. Bernstein began coverage on shares of Molina Healthcare in a report on Tuesday, April 22nd. They issued an "outperform" rating and a $414.00 target price for the company. Baird R W downgraded Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Morgan Stanley assumed coverage on shares of Molina Healthcare in a report on Monday, June 9th. They set an "overweight" rating and a $364.00 price objective on the stock. Robert W. Baird reiterated a "neutral" rating and issued a $375.00 target price (up from $331.00) on shares of Molina Healthcare in a research note on Tuesday, April 15th. Finally, Mizuho boosted their target price on shares of Molina Healthcare from $376.00 to $400.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Ten research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $364.21.

Molina Healthcare Stock Performance

NYSE MOH traded up $0.51 on Friday, reaching $239.51. 788,916 shares of the company's stock traded hands, compared to its average volume of 705,377. Molina Healthcare, Inc has a fifty-two week low of $236.37 and a fifty-two week high of $365.23. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.63 and a current ratio of 1.63. The firm has a market cap of $12.98 billion, a price-to-earnings ratio of 11.56, a P/E/G ratio of 0.80 and a beta of 0.55. The stock has a 50 day moving average price of $302.25 and a 200-day moving average price of $305.47.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.96 by $0.12. The business had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The company's revenue for the quarter was up 12.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $5.73 EPS. Equities research analysts predict that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.